Vertex to Participate in Upcoming Investor Conferences
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Charles Wagner, Executive Vice President and Chief Financial Officer, and David Altshuler, M.D., Ph.D., Executive Vice President, Global Research, and Chief Scientific Officer, will participate in two upcoming investor conferences:
- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Charles Wagner, Executive Vice President and Chief Financial Officer, and David Altshuler, M.D., Ph.D., Executive Vice President, Global Research, and Chief Scientific Officer, will participate in two upcoming investor conferences:
TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 at 10:30 a.m. - Leerink Partners Global Biopharma Conference on Monday, March 11, 2024 at 4:00 p.m.
- A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page.
- A replay of the conference webcast will be archived on the company's website.